SG26364G - 2', 3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections - Google Patents

2', 3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections

Info

Publication number
SG26364G
SG26364G SG1995904231A SG1995904231A SG26364G SG 26364 G SG26364 G SG 26364G SG 1995904231 A SG1995904231 A SG 1995904231A SG 1995904231 A SG1995904231 A SG 1995904231A SG 26364 G SG26364 G SG 26364G
Authority
SG
Singapore
Prior art keywords
dideoxy
fluorothymidine
treatment
related compounds
adenovirus infections
Prior art date
Application number
SG1995904231A
Other languages
English (en)
Inventor
John William Talbot Selway
Beacham Lowrie Miller Iii
Susan Mary Daluge
Joel Van Tuttle
Thomas Anthony Krenitsky
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SG26364G publication Critical patent/SG26364G/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
SG1995904231A 1987-08-22 1988-08-19 2', 3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections SG26364G (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878719877A GB8719877D0 (en) 1987-08-22 1987-08-22 Antiviral compounds

Publications (1)

Publication Number Publication Date
SG26364G true SG26364G (en) 1995-09-18

Family

ID=10622673

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1995904231A SG26364G (en) 1987-08-22 1988-08-19 2', 3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections

Country Status (19)

Country Link
US (2) US5070078A (pt)
EP (2) EP0305117B1 (pt)
JP (1) JP2634202B2 (pt)
KR (1) KR890003382A (pt)
AT (1) ATE82681T1 (pt)
AU (1) AU613659B2 (pt)
CA (1) CA1333361C (pt)
DE (1) DE3876174T2 (pt)
DK (3) DK169657B1 (pt)
ES (1) ES2052732T3 (pt)
GB (1) GB8719877D0 (pt)
GR (1) GR3006510T3 (pt)
HU (1) HU211666A9 (pt)
IE (2) IE63655B1 (pt)
MX (1) MX9203416A (pt)
NZ (1) NZ225881A (pt)
PT (1) PT88306B (pt)
SG (1) SG26364G (pt)
ZA (1) ZA886182B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8719877D0 (en) * 1987-08-22 1987-09-30 Wellcome Found Antiviral compounds
GB8726136D0 (en) * 1987-11-07 1987-12-09 Wellcome Found Therapeutic nucleosides
US5157114A (en) * 1988-08-19 1992-10-20 Burroughs Wellcome Co. 2',3'-dideoxy-3'-fluoro-5-ethyngluridine
WO1990003978A1 (en) * 1988-10-03 1990-04-19 Stichting Rega Vzw 5-halogeno-3'-fluoro-2',3'-dideoxyuridine compounds and their therapeutic application
GB9003543D0 (en) * 1990-02-16 1990-04-11 Wellcome Found Therapeutic nucleosides
US5166327A (en) * 1990-07-31 1992-11-24 Yuki Gosei Kogyo Co., Ltd. Process for producing 3'-deoxy-3-'-fluorothymidine
JP2804184B2 (ja) * 1991-05-14 1998-09-24 シャープ株式会社 ファクシミリ装置
DE4121001C1 (pt) * 1991-06-21 1993-05-06 Max-Delbrueck-Centrum Fuer Molekulare Medizin Berlin-Buch, O-1115 Berlin, De
US5341595A (en) * 1992-06-15 1994-08-30 Environmental Growth Chambers Environmental chamber for plant growth analysis
GB9309787D0 (en) * 1993-05-12 1993-06-23 Rhone Poulenc Chemicals Purification of fluoronucleosides
EP0698032B1 (en) * 1993-05-12 1998-07-29 Rhodia Limited Preparation of fluoro-nucleosides and intermediates for use therein
SE503787C2 (sv) * 1994-12-07 1996-09-02 Electrolux Ab Anordning för att tillhandahålla kylda eller frysta varor
US5690202A (en) * 1996-04-15 1997-11-25 Myers; John E. Overrunning clutch mechanism
US6514979B1 (en) 1999-03-03 2003-02-04 University Of Maryland Biotechnology Institute Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor
US6855561B2 (en) * 2001-09-10 2005-02-15 Quidel Corporation Method for adding an apparent non-signal line to a lateral flow assay
US20030236218A1 (en) * 2002-06-12 2003-12-25 Uckun Fatih M. Aryl phosphate derivatives of d4T with selective activity against adenovirus and HIV
KR20050013628A (ko) * 2002-06-27 2005-02-04 메디비르 아베 아바카비르와 알로부딘의 공동상승 상호작용
CN1248266C (zh) * 2002-12-26 2006-03-29 邱智铭 一种转动式电开关结构
US20050131224A1 (en) * 2003-12-15 2005-06-16 Cti Pet Systems, Inc. Method for preparing radiolabeled thymidine
US7160537B2 (en) * 2003-12-15 2007-01-09 Siemens Medical Solutions Usa, Inc. Method for preparing radiolabeled thymidine having low chromophoric byproducts
RU2628456C1 (ru) * 2016-06-29 2017-08-17 Федеральное Государственное Бюджетное Учреждение Науки Институт Молекулярной Биологии Им. В.А. Энгельгардта Российской Академии Наук (Имб Ран) Новые пиримидиновые ингибиторы репликации аденовируса человека

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE103241C (pt) *
GB1251828A (pt) * 1968-12-19 1971-11-03
DE1913384C2 (de) * 1968-12-20 1982-12-16 Akademie Der Wissenschaften Der Ddr, Ddr 1199 Berlin 1-(2',3'-Didesoxy-3'-fluor-β-D-xylofuranosyl)-thymin, Verfahren zu seiner Herstellung und dieses enthaltende Cytostatica
GB1189973A (en) * 1969-02-14 1970-04-29 Akad Wissenschaften Ddr Cytostatically-Active 2',3'-Didesoxy-3'-Fluoropyrimidine-Nucleosides
US3775397A (en) * 1969-11-12 1973-11-27 Akad Wissenschaften Ddr Novel cytostatic 2',3'-dideoxy-3'-fluoropyrimidine-nucleosides
DD103241A1 (pt) * 1972-12-12 1974-01-12
EP0265431A1 (de) * 1985-07-23 1988-05-04 WOLF, Karl Schaltungsanordnung zum starten und zum betrieb mindestens einer niederdruck- oder hochdruck-gasentladungslampe mit hochfrequenten schwingungen
ATE190064T1 (de) * 1985-09-17 2000-03-15 Wellcome Found Kombination therapeutische nukleoside mit weiteren therapeutisch wirksamen komponenten.
US4710492A (en) * 1986-06-23 1987-12-01 Yale University 3'-azido-2',3'-dideoxy-5-halouridine and its use in treating patients infected with retroviruses
SE8602981D0 (sv) * 1986-07-04 1986-07-04 Astra Laekemedel Ab Novel medicinal use
DD279407A1 (de) * 1986-07-24 1990-06-06 Akad Wissenschaften Ddr Verfahren zur herstellung eines mittels gegen aids
EP0332626A1 (en) * 1986-11-21 1989-09-20 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Compositions for treating viral infections in humans
US4880782A (en) * 1986-11-21 1989-11-14 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Method of treating viral infections in humans and compositions therefor
GB8719877D0 (en) * 1987-08-22 1987-09-30 Wellcome Found Antiviral compounds
WO1990003978A1 (en) * 1988-10-03 1990-04-19 Stichting Rega Vzw 5-halogeno-3'-fluoro-2',3'-dideoxyuridine compounds and their therapeutic application

Also Published As

Publication number Publication date
DK169437B1 (da) 1994-10-31
EP0479336A1 (en) 1992-04-08
DK468288A (da) 1989-02-23
DK140393A (da) 1993-12-17
IE63655B1 (en) 1995-05-31
GB8719877D0 (en) 1987-09-30
EP0305117B1 (en) 1992-11-25
EP0305117A3 (en) 1989-12-27
US5376644A (en) 1994-12-27
DK140393D0 (da) 1993-12-17
IE882533L (en) 1989-02-22
DE3876174T2 (de) 1993-04-01
ZA886182B (en) 1990-04-25
DE3876174D1 (de) 1993-01-07
JP2634202B2 (ja) 1997-07-23
NZ225881A (en) 1991-03-26
ATE82681T1 (de) 1992-12-15
IE940696L (en) 1989-02-22
MX9203416A (es) 1992-07-01
DK91692D0 (da) 1992-07-14
EP0305117A2 (en) 1989-03-01
KR890003382A (ko) 1989-04-14
PT88306B (pt) 1995-12-29
DK91692A (da) 1992-07-14
US5070078A (en) 1991-12-03
CA1333361C (en) 1994-12-06
PT88306A (pt) 1989-06-30
DK468288D0 (da) 1988-08-19
DK169657B1 (da) 1995-01-09
HU211666A9 (en) 1995-12-28
GR3006510T3 (pt) 1993-06-30
AU613659B2 (en) 1991-08-08
ES2052732T3 (es) 1994-07-16
JPS6468325A (en) 1989-03-14
AU2142988A (en) 1989-05-25

Similar Documents

Publication Publication Date Title
EP0305117A3 (en) 2',3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections
ES8801303A1 (es) Un procedimiento para preparar una formulacion farmaceutica que contiene un 2'3'-didesoxi-nucleosido.
HU9302496D0 (en) Method for producing anti-viral nucleoside combinations and one for preparing medical preparatives containing said compounds
MY104069A (en) Therapeutic nucleosides
WO1999038877A3 (en) 2-(PURIN-9-yl)-TETRAHYDROFURAN-3,4-DIOL DERIVATIVES
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
IL85945A0 (en) Pharmaceutical compositions containing 2'-fluoronucleosides and derivatives thereof,certain such novel compounds and their preparation
NO20005332L (no) 1,6-GPS-(6-O-α-D-glukopyranosyl-D-sorbit) og 1,1-GPM-(1-O-α-D-glukopyranosyl-D-mannit)-holdig sukkeralkoholblanding for bruk som terapeutisk aktivt stoff samt legemiddel inneholdende nevnte blanding
NZ324380A (en) Therapeutic benzimidazole compounds and their use in treatment of virus infections
NO965483L (no) Dinukleosid-5',5'-pyrofosfater
ES8301244A1 (es) Procedimiento para la obtencion de derivados de sisomicina.
MY105855A (en) Therapeutic nucleotides.
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
ES8304152A1 (es) Procedimiento para la obtencion de derivzados de aminociclitol.
MY111746A (en) Therapeutic nucleosides.
DK0742716T3 (da) Farmaceutisk sammensætning til systemisk transdermal indgivelse med det aktive middel morphin-6-glucuronid
AU4910590A (en) Pyrimidinetrione derivatives, processes for their preparation, agents containing them and their use as agents for combating pests
FR2527630B1 (fr) Enzyme leucocytaire humaine de type pepsique, procede pour sa preparation et agent therapeutique la contenant
AU2506188A (en) Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance